Serotonin transporter binding and motor onset of Parkinson's disease in asymptomatic LRRK2 mutation carriers: a cross-sectional study

BACKGROUND: Patients with Parkinson’s Disease (PD) may exhibit premotor neurochemical changes in dopaminergic (DA) and nondopaminergic systems. Using positron emission tomography (PET), we studied participants with leucine-rich repeat kinase 2 (LRRK2) mutations and with sporadic PD to assess whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Wile, Daryl J, Agarwal, Pankaj A, Schulzer, Michael, Mak, Edwin, Dinelle, Katherine, Shahinfard, Elham, Vafai, Nasim, Hasegawa, Kazuko, Zhang, Jing, McKenzie, Jessamyn, Neilson, Nicole, Strongosky, Audrey, Uitti, Ryan J, Guttman, Mark, Zabetian, Cyrus P, Ding, Yu-Shin, Adam, Mike, Aasly, Jan, Wszolek, Zbigniew K, Farrer, Matthew, Sossi, Vesna, Stoessl, A Jon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477770/
https://www.ncbi.nlm.nih.gov/pubmed/28336296
http://dx.doi.org/10.1016/S1474-4422(17)30056-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477770/
https://www.ncbi.nlm.nih.gov/pubmed/28336296
http://dx.doi.org/10.1016/S1474-4422(17)30056-X

Ejemplares similares